Featured Job
-
Job Removed or Not Found
Related Jobs
- Merck & Co. (North Wales, PA)
- …certifications, experience, skills, geographic location, government requirements, and business or organizational needs.The successful candidate will be eligible for
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Requires a Bachelor's degree; Master's degree preferred 12+ years of experience in portfolio strategy, strategic planning or related roles within the pharmaceutical
- Novo Nordisk Inc. (Plainsboro, NJ)
- …A Bachelor's degree required. Master's degree preferred in relevant area (eg MBA, Master's in Public Health, Healthcare Economics, or related discipline) 12+ years of
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …- Group strategy: Sets the vision and strategy for the group including overall vision for a robust risk assessment, mitigation, central (statistical) monitoring and
- Taiho Oncology (Bear, DE)
- …The Director, People Business Partner - Europe will report to the General Manager Taiho Oncology Europe, working closely with Taiho Oncology's Chief People Officer and
- Novo Nordisk Inc. (WA)
- …JD or advanced degree required 8+ years of policy development, advocacy, legal, government affairs or other relevant experience required Expert knowledge of issues within
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …across the alliance include knowledge of/training of patient support programs and reimbursement. This person will also be responsible for redesigning new hire training in
- Twist BioScience (South San Francisco, CA)
- …Leadership:Develop and execute a comprehensive business development strategy that supports the expansion and commercialization of Twist's NGS and Synthetic Biology
- Eisai, Inc (Nutley, NJ)
- …The Executive Director, Regulatory Affairs will provide leadership and direction for the global regulatory aspects of Eisai's products under development and post approval
- Merck & Co. (Rahway, NJ)
- …in biological science or related disciplineB.S., with minimum of 7 years of relevant drug development experienceM.S. with minimum of 5 years relevant drug development